2026. Regulatory Submission Intelligence and Benefit-Risk Signal Extraction: AI-Driven Frameworks for Optimising Drug Approval Pathway Navigation. Internet of Things and Edge Computing Journal. 6, 1 (Jun. 2026), 22–30.